With two new drugs approved by the FDA, a National Plan signed into law and many advances in our understanding of Parkinson’s disease, 2024 has been a transformative year in Parkinson’s research. Tune into audio from this month’s Third Thursdays Webinar to hear research experts from industry and academia talk with MJFF staff about the latest research on disease biology and emerging therapies.
Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0
The Foundation’s landmark study, the Parkinson’s Progression Marker’s Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi.
Mentioned in this episode:
Last year’s biomarker breakthrough is moving us closer to understanding the root cause of Parkinson’s. This is the tipping point that could lead to a cure. Help us accelerate more life-changing breakthroughs by visiting michaeljfox.org/givetoresearch to donate today.